RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles see all

Displaying items 1-5
  • Charles Farthing dies at 60; doctor at forefront of AIDS care

    Charles Farthing dies at 60; doctor at forefront of AIDS care
    Charles F. Farthing, a physician who was at the forefront of care for HIV/AIDS patients and who drew attention to the need for an AIDS vaccine by announcing his willingness to inject himself, has died. He was 60.
  • Stocks close higher; Sonic soars

    Stocks close higher; Sonic soars
    Stocks got a lift Tuesday as health care companies bounced back after a heavy sell-off. Biotechnology stocks in the Standard & Poor's 500 index rose for the first time in five days after a sharp sell-off that was prompted by complaints from lawmakers...

    Exploring therapeutic effects of MDMA on post-traumatic stress

    Exploring therapeutic effects of MDMA on post-traumatic stress
    It costs about $2,000 to buy an ounce of the illegal drug, the therapist said — enough for roughly 150 doses. She pays her longtime dealer in cash; he gives her a Ziploc bag of white powder. Back home, she scoops the contents into clear capsules....

    Toyota may pay $1 billion to settle federal criminal investigation

    Toyota may pay $1 billion to settle federal criminal investigation
    Here's how Toyota Motor Corp. plans to finally put the sudden-acceleration issue to rest: Pull out the checkbook. The automaker is reportedly close to paying a $1-billion fine to settle a four-year federal criminal investigation into whether it properly...

    U.S. venture gathers 10 drug makers to fight Alzheimer's, diabetes

    U.S. venture gathers 10 drug makers to fight Alzheimer's, diabetes
    Pfizer Inc., Eli Lilly & Co. and eight other large drug makers will partner with the U.S. government in a $230-million effort to identify new approaches to treat Alzheimer's, diabetes, lupus and arthritis. Data generated from the work will be made...